The LOHGIC algorithm is currently being used to analyze tumor sequencing assay results as part of the Rutgers Cancer Institute's precision medicine program.
The new, open-source GATK4 widens its coverage and compatibility with major cloud platforms while adding machine learning.
The partners will integrate genomic, imaging, and other data to identify new therapies and personalize treatments for patients with neurological and neurodegenerative diseases.
A study of gene expression data from 173 breast cancer patients identified subtype-specific associations between molecular processes in tumor and blood cells.
The British CRISPR software developer is turning to investment platform SyndicateRoom as it looks to commercialize its products and expand into the US.
The new distributor of DNAStar sequencing analysis software in Japan is a longtime partner of the Wisconsin software company.
The open-source MultiQC software platform aggregates multiple bioinformatics analyses into a single report for the purpose of quality control.
A CIO panel discussed why genomics IT is prepared for new security challenges and why organizations need to step up staff training and retention strategies.
The company is integrating its newly purchased LIMS and genome interpretation and reporting capabilities to provide a single platform for cancer and inherited disease diagnostics.
The Pinnacle assay for gene fusions and gene expression in tumor samples is the first in Cofactor's new line of clinical RNA-sequencing assays.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.